Elwehidy Ahmed S
In this database
7
2019 โ 2025
DB Citations
39
across indexed articles
h-index
โ
Not available
Total Citations
โ
Not available
7 articles in Glaucoma Journal Club
Ahmed Glaucoma Valve Revision Versus Visco-Trabeculotomy After Failed Ahmed Glaucoma Valve in Refractory Pediatric Glaucoma.
Both VT and AGV revision are reasonably successful and safe interventions for refractory childhood glaucoma after the failure of an AGV.
Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy Versus Rigid Probe Trabeculotomy in Primary Congenital Glaucoma: A 3-Year Randomized Controlled Study.
Both VCST and VT were effective and safe for lowering the IOP in PCG with VCST providing a marginal advantage over VT.
Combined phacoemulsification-viscosynechialysis-trabeculotomy vs phacotrabeculectomy in uncontrolled primary angle-closure glaucoma with cataract.
Although both techniques were relatively safe and effective in reducing IOP for at least 2 years in eyes with PACG, combined phacoemulsification-viscosynechialysis-trabeculotomy gave better outcomes.
Visco-Circumferential-Suture-Trabeculotomy Versus Rigid-Probe Viscotrabeculotomy in Neonatal-Onset Primary Congenital Glaucoma.
Angle procedures are safe and marginally effective for the surgical treatment of neonatal-onset PCG, bringing IOP under control for at least 4 years of follow-up.
A Comparative Study of Ocular Surface Disease in Childhood Glaucoma.
In this first study to comprehensively evaluate OSD in patients with CG, a significantly greater incidence of OSD signs and symptoms was found in patients with CG compared with a healthy population.
The effect of treatment of primary congenital glaucoma on meibomian glands and tear film.
In this first study to evaluate MG and tear film parameters in treated PCG, significant differences were observed in the MG morphology and tear film parameters of eyes with treated PCG compared to the eyes of healthy children.
Response: Ahmed Glaucoma Valve Revision Versus Viscotrabeculotomy After Failed Ahmed Glaucoma Valve in Refractory Pediatric Glaucoma.